A CRO can have useful AI opportunities before applying a model to study data or scientific conclusions. Client services may spend hours finding approved capability statements, and IT may answer the same internal questions repeatedly. Supplier questionnaires often have to be assembled from documents with different owners and review dates.
Those are concrete places to begin. An assistant can retrieve approved information and prepare an answer for review, while the organization decides separately which regulated uses it is prepared to support.
The starting point is intended use. Discovery services, preclinical work, and clinical trial operations have different records and responsibilities, so a project described only as AI for CROs is not specific enough to design or approve.
Choose a first task with a clear owner
A capability response assistant is a useful example. It retrieves approved descriptions of services, facilities, and policies, then drafts an answer to a client question.
The source collection should be small enough to govern. Each document needs an owner, a current status, a review date, and rules for reuse. A statement approved for one purpose or client should not automatically become a general response.
The assistant should show the supporting passages and identify gaps. When it cannot find an approved answer, the question goes to the responsible owner, because the assistant must not invent a certification, service commitment, or method validation status.
Draw the data boundary technically
A policy can define prohibited use, but the system must also enforce it. If the assistant can retrieve excluded study records, a statement in the prompt is not a sufficient boundary.
Limit the connected repositories, identities, and permitted operations, then test questions that try to cross the boundary. Search results, citations, exported files, and logs should all be checked for restricted information.
Generated responses may inherit the sensitivity of their sources, so protect the answer library as carefully as the documents it draws from. A broadly shared response folder can undo careful source permissions.
Keep business assistance and regulated use distinct
The FDA's January 2025 guidance page on using AI to support regulatory decision-making concerns information or data intended to support regulatory decisions about drugs and biological products. The page identifies the guidance as draft and nonbinding. It is not a blanket rule for every administrative assistant used by a research organization.
That distinction does not remove obligations from other sources. Contracts, quality agreements, privacy requirements, and the organization's own procedures can affect the proposed use.
If the project later enters study analysis, safety assessment, or regulated records, reassess the intended use, required evidence, and validation strategy through the quality process. Do not treat that change as a minor prompt update.
For European operations, review the current AI Act position and the actual system classification. The European Commission's published AI Act timeline has changed, so an old slide is a poor basis for a new deployment decision.
Understand what the platform promises
Microsoft's documentation on Copilot data privacy says covered Copilot interactions and Microsoft Graph data are not used to train foundation models, and that access follows user permissions. Those facts help the assessment but do not settle every client restriction.
Check the actual product, configuration, model provider, connectors, retention behavior, and contractual commitments. An agent that calls another service can have a different data path, and a permitted employee may also have access to more content than they should.
Write the approved architecture in plain language. Client services and quality reviewers should be able to understand what data enters the tool, what it does, what it stores, and who approves the output.
Learn from large CRO programs without copying their scope
ICON announced a technology partnership in June 2026 covering AI assistants for its employees, data infrastructure, and its own in-house AI platform. That is evidence of a major CRO investing in AI across several layers. It describes an announced program and gives no measured return for a smaller company's first workflow.
A smaller organization can start with a controlled knowledge task and expand when evidence supports it. It does not need to connect every system at once.
Run a pilot with questions that should fail
Use historical questions that have approved answers, questions with expired sources, conflicting documents, and questions outside the permitted scope. Include attempts to retrieve restricted content.
Measure source support, unsupported claims, correct escalation, and total preparation plus review time. Keep external answers under human approval, with the reviewer able to see where each important claim came from.
A correct refusal is useful when the question is outside scope. Too many refusals on ordinary work can show that the source collection is incomplete. Report both, so safety and usefulness can be assessed together.
Build the economic case around actual tasks
Suppose a hypothetical team handles 400 individual response tasks per month, as opposed to 400 full proposals. If total work falls from 45 to 25 minutes, the recovered capacity is about 133 hours.
At an assumed $65 loaded hourly cost and 60% realization, useful capacity is valued at $5,200. After $1,800 in monthly operating cost, hypothetical net capacity value is $3,400.
Replace every assumption with observed data. Avoid assigning a speculative dollar amount to avoided regulatory problems or lost deals, and track evidence such as response turnaround, traceable claims, and fewer corrections instead.
Take a specific workflow to discovery
QueryNow's AI governance services for life sciences can support a defined rollout alongside the technical work, and our page on AI for preclinical CROs covers the operational side, such as quotes and study reports. Bring one workflow, the approved sources, a few difficult questions, and the client restrictions that matter.
The first deliverable should explain what the assistant is allowed to do, what it can access, how it will be tested, and who will approve the result. That gives the business and quality teams a concrete project to assess.
Questions CRO leaders ask
Should we begin with scientific outputs?
Only where the intended use, data, controls, and quality requirements are ready. Administrative knowledge work can offer a more bounded first project.
Is a private cloud enough?
It is one architectural choice. Permissions, provider terms, contracts, retention, and output controls still need review.
What should the pilot prove?
Supported answers, correct handling of unknowns, enforcement of the data boundary, and reduced total work after review.
Ready to ship AI in your organization?
We build one workflow into a working tool in two weeks. You pay $10,000 only after every acceptance criterion you signed off on is met.
One workflow · Two-week build · $10,000, paid on delivery
QueryNow
QueryNow deploys production AI for enterprises on Azure, AWS, or Google Cloud. Founded in 2014, we help pharma, healthcare, manufacturing, and financial services organizations deploy governed AI systems. We build it, you pay when it works.
Learn more about us →


